• 1. Medical Device Regulatory Research and Evaluation Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Department of Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
YUE Jirong, Email: yuejirong11@hotmail.com; HUANG Jin, Email: michael_huangjin@163.com; DONG Birong, Email: birongdong@163.com
Export PDF Favorites Scan Get Citation

Sarcopenia, characterized by the progressive loss of muscle mass and function, predominantly afflicts older adults. This condition is a notable risk factor for functional impairments, increased incidence of falls and fractures, and can escalate to mortality. Timely intervention is crucial to mitigate disability and minimize complications during hospitalization. The development of these guidelines adhered to an internationally recognized standard protocol. This involved framing clinical queries, pinpointing key outcomes, systematically gathering evidence, and appraising this evidence through the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. Subsequently, a consortium of experts convened to deliberate over the evidence, culminating in the formulation of these recommendations.

Citation: SHEN Yanjiao, HAO Qiukui, ZHANG Meng, XIAN Hong, YUE Jirong, HUANG Jin, DONG Birong. Comprehensive intervention for sarcopenia among older adults: an evidence-based clinical practice guideline. Chinese Journal of Evidence-Based Medicine, 2024, 24(4): 378-384. doi: 10.7507/1672-2531.202306172 Copy

  • Previous Article

    The application of large language models in the field of evidence-based medicine
  • Next Article

    Guidelines for high-flow nasal cannula oxygen therapy in neonates (2023)